Amedeo Smart

Free Medical Literature Service


 

Amedeo

Colorectal Neoplasms

  Free Subscription

Articles published in
Oncology
    September 2017
  1. CICERO G, De Luca R, Dieli F
    Efficacy and Safety of the Oral Multikinase Regorafenib in Metastatic Colorectal Cancer.
    Oncology. 2017 Sep 6. doi: 10.1159/000479112.
    >> Share

  2. KOMORI A, Taniguchi H, Hamauchi S, Masuishi T, et al
    Serum CA19-9 Response Is an Early Predictive Marker of Efficacy of Regorafenib in Refractory Metastatic Colorectal Cancer.
    Oncology. 2017 Sep 2. doi: 10.1159/000479280.
    >> Share

    July 2017
  3. NOZAWA H, Ishihara S, Kawai K, Sasaki K, et al
    Brain Metastasis from Colorectal Cancer: Predictors and Treatment Outcomes.
    Oncology. 2017 Jul 13. doi: 10.1159/000478661.
    >> Share

    May 2017
  4. LARSEN FO, Markussen A, Nielsen D, Colville-Ebeling B, et al
    Dual Inhibition of EGFR and VEGF in Heavily Pretreated Patients with Metastatic Colorectal Cancer.
    Oncology. 2017 May 23. doi: 10.1159/000475818.
    >> Share

    April 2017
  5. LIM KH, Lee HY, Park SB, Song SY, et al
    Feasibility of Modified FOLFOX in Elderly Patients Aged >/=80 Years with Metastatic Gastric Cancer or Colorectal Cancer.
    Oncology. 2017 Apr 27. doi: 10.1159/000471767.
    >> Share

  6. TSUKAMOTO M, Iinuma H, Yagi T, Matsuda K, et al
    Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
    Oncology. 2017;92.
    >> Share

    February 2017
  7. SAITO G, Sadahiro S, Kamata H, Miyakita H, et al
    Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence.
    Oncology. 2017 Feb 9. doi: 10.1159/000456075.
    >> Share

  8. HASEGAWA H, Taniguchi H, Mitani S, Masuishi T, et al
    Efficacy of Second-Line Bevacizumab-Containing Chemotherapy for Patients with Metastatic Colorectal Cancer following First-Line Treatment with an Anti-Epidermal Growth Factor Receptor Antibody.
    Oncology. 2017 Feb 1. doi: 10.1159/000453336.
    >> Share

    January 2017
  9. NOZAWA H, Ishihara S, Kawai K, Hata K, et al
    Characterization of Conversion Chemotherapy for Secondary Surgical Resection in Colorectal Cancer Patients with Lung Metastases.
    Oncology. 2017;92:135-141.
    >> Share

  10. KASAGI Y, Oki E, Ando K, Ito S, et al
    The Expression of CCAT2, a Novel Long Noncoding RNA Transcript, and rs6983267 Single-Nucleotide Polymorphism Genotypes in Colorectal Cancers.
    Oncology. 2017;92:48-54.
    >> Share

  11. KIM DW, Byer J, Kothari N, Mahipal A, et al
    EGFR Inhibitors in Patients with Advanced Squamous Cell Anal Carcinomas: A Single-Institution Experience.
    Oncology. 2017;92:190-196.
    >> Share

    December 2016
  12. YANG CA, Huang HY, Chang YS, Lin CL, et al
    DNA-Sensing and Nuclease Gene Expressions as Markers for Colorectal Cancer Progression.
    Oncology. 2016;92.
    >> Share

  13. ALDIAB A, Al Khayal KA, Al Obaid OA, Alsheikh A, et al
    Clinicopathological Features and Predictive Factors for Colorectal Cancer Outcome in the Kingdom of Saudi Arabia.
    Oncology. 2016.
    >> Share

    October 2016
  14. ABE S, Kawai K, Ishihara S, Nozawa H, et al
    Prognostic Value of Pre- and Postoperative Anti-p53 Antibody Levels in Colorectal Cancer Patients: A Retrospective Study.
    Oncology. 2016.
    >> Share

    August 2016
  15. PAOLICCHI E, Vivaldi C, De Gregorio V, Crea F, et al
    Topoisomerase 1 Promoter Variants and Benefit from Irinotecan in Metastatic Colorectal Cancer Patients.
    Oncology. 2016.
    >> Share

  16. SUGITA K, Kawakami K, Yokokawa T, Sugisaki T, et al
    Self-Reported Adherence to Trifluridine and Tipiracil Hydrochloride for Metastatic Colorectal Cancer: A Retrospective Cohort Study.
    Oncology. 2016;91:224-230.
    >> Share

    July 2016
  17. AMAKI-TAKAO M, Yamaguchi T, Natsume S, Iijima T, et al
    Colorectal Cancer with BRAF D594G Mutation Is Not Associated with Microsatellite Instability or Poor Prognosis.
    Oncology. 2016.
    >> Share

  18. NOZAWA H, Ishihara S, Kawai K, Murono K, et al
    Paradoxical Reductions in Serum Anti-p53 Autoantibody Levels by Chemotherapy in Unresectable Colorectal Cancer: An Observational Study.
    Oncology. 2016.
    >> Share

    June 2016
  19. SAITO G, Sadahiro S, Okada K, Tanaka A, et al
    Relation between Carcinoembryonic Antigen Levels in Colon Cancer Tissue and Serum Carcinoembryonic Antigen Levels at Initial Surgery and Recurrence.
    Oncology. 2016.
    >> Share

    May 2016
  20. YOSHIDA M, Takagane A, Miyake Y, Shimada K, et al
    A Phase II Study of Third-Line Combination Chemotherapy with Bevacizumab Plus S-1 for Metastatic Colorectal Cancer with Mutated KRAS (SAVIOR Study).
    Oncology. 2016.
    >> Share

    January 2016
  21. CHOI EJ, Yoo NJ, Kim MS, An CH, et al
    Putative Tumor Suppressor Genes EGR1 and BRSK1 Are Mutated in Gastric and Colorectal Cancers.
    Oncology. 2016;91:289-294.
    >> Share

  22. KOHLER C, Marnitz S, Biel P, Cordes T, et al
    Successful Delivery in a 39-Year-Old Patient with Anal Cancer after Fertility-Preserving Surgery Followed by Primary Chemoradiation and Low Anti-Mullerian Hormone Level.
    Oncology. 2016;91:295-298.
    >> Share

  23. RUBIO I, Ibanez-Feijoo E, Andres L, Aguirre E, et al
    Analysis of Lynch Syndrome Mismatch Repair Genes in Women with Endometrial Cancer.
    Oncology. 2016;91:171-6.
    >> Share

  24. KHAN AA, Akritidis G, Pring T, Alagarathnam S, et al
    The Neutrophil-to-Lymphocyte Ratio as a Marker of Lymph Node Status in Patients with Rectal Cancer.
    Oncology. 2016;91:69-77.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016